S. Grootenboer‐Mignot

1.1k total citations
25 papers, 599 citations indexed

About

S. Grootenboer‐Mignot is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, S. Grootenboer‐Mignot has authored 25 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 14 papers in Pathology and Forensic Medicine and 7 papers in Genetics. Recurrent topics in S. Grootenboer‐Mignot's work include Autoimmune Bullous Skin Diseases (14 papers), Urticaria and Related Conditions (9 papers) and Systemic Lupus Erythematosus Research (6 papers). S. Grootenboer‐Mignot is often cited by papers focused on Autoimmune Bullous Skin Diseases (14 papers), Urticaria and Related Conditions (9 papers) and Systemic Lupus Erythematosus Research (6 papers). S. Grootenboer‐Mignot collaborates with scholars based in France, United States and Norway. S. Grootenboer‐Mignot's co-authors include Sylvie Chollet‐Martin, P. Nicaise‐Roland, Olivier Meyer, Gilles Hayem, Margarita Hurtado-Nédelec, Raymond Ruimy, Philippe Dieudé, C. Prost‐Squarcioni, Élisabeth Palazzo and F. Caux and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Lancet Oncology and Frontiers in Immunology.

In The Last Decade

S. Grootenboer‐Mignot

23 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Grootenboer‐Mignot France 14 394 220 138 85 80 25 599
Cumhur İbrahim Başsorgun Türkiye 11 202 0.5× 183 0.8× 140 1.0× 56 0.7× 80 1.0× 44 466
Delphine Giusti France 10 191 0.5× 181 0.8× 81 0.6× 167 2.0× 41 0.5× 36 478
N. Cordel France 14 406 1.0× 335 1.5× 207 1.5× 82 1.0× 56 0.7× 57 745
Naoya Sekiguchi Japan 15 523 1.3× 129 0.6× 142 1.0× 81 1.0× 110 1.4× 29 685
Theodora E. Markatseli Greece 14 366 0.9× 243 1.1× 50 0.4× 277 3.3× 118 1.5× 36 739
Hakan M. Gürcan United States 12 244 0.6× 332 1.5× 238 1.7× 141 1.7× 31 0.4× 12 582
Françoise Aucouturier France 12 342 0.9× 463 2.1× 375 2.7× 71 0.8× 23 0.3× 16 682
S Songcharoen United States 6 421 1.1× 98 0.4× 123 0.9× 141 1.7× 29 0.4× 7 654
Hironari Hanaoka Japan 14 345 0.9× 82 0.4× 42 0.3× 121 1.4× 232 2.9× 74 613

Countries citing papers authored by S. Grootenboer‐Mignot

Since Specialization
Citations

This map shows the geographic impact of S. Grootenboer‐Mignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Grootenboer‐Mignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Grootenboer‐Mignot more than expected).

Fields of papers citing papers by S. Grootenboer‐Mignot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Grootenboer‐Mignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Grootenboer‐Mignot. The network helps show where S. Grootenboer‐Mignot may publish in the future.

Co-authorship network of co-authors of S. Grootenboer‐Mignot

This figure shows the co-authorship network connecting the top 25 collaborators of S. Grootenboer‐Mignot. A scholar is included among the top collaborators of S. Grootenboer‐Mignot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Grootenboer‐Mignot. S. Grootenboer‐Mignot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohelay, G., M. Alexandre, Antoine Martin, et al.. (2024). Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review. Frontiers in Immunology. 15. 1243566–1243566.
2.
Descamps, V., François Chasset, T. Mahévas, et al.. (2022). Erythema multiforme associated with anti‐plakin antibodies: a multicentric retrospective case series. Journal of the European Academy of Dermatology and Venereology. 36(12). 2438–2442. 5 indexed citations
3.
Bohelay, G., M. Alexandre, C. Le Roux‐Villet, et al.. (2022). Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients. Frontiers in Immunology. 13. 915205–915205. 9 indexed citations
4.
Alexandre, M., G. Bohelay, Thomas Gille, et al.. (2022). Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients. Frontiers in Immunology. 13. 874108–874108. 11 indexed citations
5.
Yatim, Ahmad, G. Bohelay, S. Grootenboer‐Mignot, et al.. (2019). Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa. Frontiers in Medicine. 6. 249–249. 19 indexed citations
6.
Prost‐Squarcioni, C., F. Tétart, Benoît Bensaïd, et al.. (2018). Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases. British Journal of Clinical Pharmacology. 85(3). 570–579. 39 indexed citations
7.
Haroche, Julien, Philippe Moguelet, S. Grootenboer‐Mignot, et al.. (2017). Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases. Seminars in Arthritis and Rheumatism. 48(1). 83–89. 48 indexed citations
8.
Hotz, Claire, Nicolás Ortonne, S. Grootenboer‐Mignot, et al.. (2017). A polymorphous bullous dermatosis. The Lancet Oncology. 18(12). e776–e776.
9.
Gottlieb, J., S. Oro, M. Alexandre, et al.. (2016). Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. British Journal of Dermatology. 177(1). 212–222. 34 indexed citations
10.
Oro, S., C. Fite, L. Valeyrie‐Allanore, et al.. (2015). Rituximab, a new treatment for difficult‐to‐treat chronic erythema multiforme major? Five cases. Journal of the European Academy of Dermatology and Venereology. 30(7). 1140–1143. 10 indexed citations
11.
Oro, S., Sophie Hüe, S. Grootenboer‐Mignot, & Claire André. (2013). Auto-anticorps des dermatoses bulleuses auto-immunes (pemphigus, pemphigoïde bulleuse) : ce que le dermatologue doit savoir. Annales de Dermatologie et de Vénéréologie. 140(8-9). 563–570. 5 indexed citations
12.
Nicaise‐Roland, P., Léonor Nogueira, Christophe Dematteï, et al.. (2013). Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort. Annals of the Rheumatic Diseases. 72(3). 357–362. 36 indexed citations
13.
Taillé, Camille, S. Grootenboer‐Mignot, Céline Boursier, et al.. (2010). Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 183(6). 759–766. 78 indexed citations
14.
Nicaise‐Roland, P., Gilles Hayem, Élisabeth Palazzo, et al.. (2009). Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis. Joint Bone Spine. 76(3). 248–253. 35 indexed citations
15.
Meyer, Olivier, P. Nicaise‐Roland, S. Grootenboer‐Mignot, et al.. (2009). Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 11(3). R87–R87. 47 indexed citations
16.
Grootenboer‐Mignot, S., V. Descamps, C. Picard‐Dahan, et al.. (2009). Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses. British Journal of Dermatology. 162(4). 743–750. 32 indexed citations
17.
Hurtado-Nédelec, Margarita, Sylvie Chollet‐Martin, P. Nicaise‐Roland, et al.. (2008). Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Lara D. Veeken. 47(8). 1160–1167. 111 indexed citations
18.
Grootenboer‐Mignot, S., et al.. (2004). Second generation anti‐cyclic citrullinated peptide (anti‐CCP2) antibodies can replace other anti‐filaggrin antibodies and improve rheumatoid arthritis diagnosis. Scandinavian Journal of Rheumatology. 33(4). 218–220. 17 indexed citations
19.
Carella, Massimo, Pio D’Adamo, S. Grootenboer‐Mignot, et al.. (2004). A second locus mapping to 2q35–36 for familial pseudohyperkalaemia. European Journal of Human Genetics. 12(12). 1073–1076. 17 indexed citations
20.
Grootenboer‐Mignot, S., Aurore Crétien, Ingrid Laurendeau, et al.. (2003). Sub‐lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies. Prenatal Diagnosis. 23(5). 380–384. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cumhur İbrahim Başsorgun Breakdown of academic impact, for papers by Delphine Giusti Breakdown of academic impact, for papers by N. Cordel Breakdown of academic impact, for papers by Naoya Sekiguchi Breakdown of academic impact, for papers by Theodora E. Markatseli Breakdown of academic impact, for papers by Hakan M. Gürcan Breakdown of academic impact, for papers by Françoise Aucouturier Breakdown of academic impact, for papers by S Songcharoen Breakdown of academic impact, for papers by Hironari Hanaoka
Rankless by CCL
2026